Spark Therapeutics’ late-stage gene therapy for inherited blindness takes a $73M step forward
A Children’s Hospital of Philadelphia spinout with the potential to be the first to win U.S. FDA approval of a gene therapy is now funded through the rest of development of its lead treatment for inherited blindness. Spark Therapeutics is in the middle of a Phase 3 clinical trial that will determine whether the gene therapy […]